LexDanaLexDanabeta
Inventor

ROBERT COFFMAN

Inventor
US

Overview

2→
Patents
2024–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes17%
C07DHeterocyclic compounds17%
C07KPeptides17%
C12NMicroorganisms or enzymes17%
PatentTitleYear
12,296,002Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)202511,981,670Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to DYNAVAX TECH CORP (2)· patent assignee history
2024–2025Based in US· patent location history
2025Patents assigned to MEDIGEN VACCINE BIOLOGICS CORP (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DYNAVAX TECH CORP22024–2025
MEDIGEN VACCINE BIOLOGICS CORP12025
Locations
LocationPatentsSpan
US22024–2025